Sofosbuvir/ledipasvir fixed dose combination is safe and effective in difficult-to-treat populations including genotype-3 patients, decompensated genotype-1 patients, and genotype-1 patients with prior sofosbuvir treatment experience [Abstract O6]

Gane EJ, Hyland RH, An D, et al. Sofosbuvir/ledipasvir fixed dose combination is safe and effective in difficult-to-treat populations including genotype-3 patients, decompensated genotype-1 patients, and genotype-1 patients with prior sofosbuvir treatment experience [Abstract O6]. In 49th European Association for the Study of the Liver International Liver Congress (EASL), April 9-13, 2014 . London, UK; 2014.

Publication Type:

Conference Paper

Source:

49th European Association for the Study of the Liver International Liver Congress (EASL), April 9-13, 2014 , Number O6, London, UK (2014)

Abstract:

O6

Top